CytoSorbents Corporation (CTSO)

Form PRE 14A - Other preliminary proxy statements

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update

CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update...

CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights

CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights PR Newswire...

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Form 8-K - Current report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights PR...

CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026

CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM...

CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights PR...

CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update

CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update PR...

CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025

CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025 PR...

Form 4 - Statement of changes in beneficial ownership of securities